InvestorsHub Logo
Followers 14
Posts 734
Boards Moderated 0
Alias Born 12/09/2013

Re: None

Wednesday, 08/23/2017 11:36:20 AM

Wednesday, August 23, 2017 11:36:20 AM

Post# of 3021
G/P Phase 3b trials; Sofosbuvir failures (in Genotype 1).

https://www.centerwatch.com/clinical-trials/listings/external-studydetails.aspx?StudyID=NCT03092375&CatID=79

https://clinicaltrials.gov/ct2/show/results/NCT03092375

I read a report that at the clinical trial site they were reporting a 97% cure rate- probably from prior trials. We will see what this trial brings in.

By the way, in visiting various HCV forums, I have not yet encountered anyone who has started w/ G/P. Forum traffic is down considerably, so weekly prescription counts may be where we see first action.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News